冠状动脉疾病患者临床表型聚类识别
研究在SWEDEHEART注册研究(n=88 894)和UCC-SMART队列(n=5506)中,用潜在类别分析对冠状动脉疾病(CAD)患者进行无监督机器学习聚类,识别出4种临床表型,并在UCC-SMART中验证。不同表型复发心血管事件风险不同,多病共存型风险最高。
要点
- CAD患者可聚类为4种临床表型,各表型复发心血管事件风险不同。
- 多病共存型(cluster 4)较cluster 1的复合终点风险最高(HR 4.38)。
- 该表型分型在UCC-SMART队列验证结果相似,具有可重复性。
核心结论
- 在CAD患者中识别出4种可重复的临床表型,且不同表型复发心血管事件风险存在差异。
研究设计与样本
- 基于SWEDEHEART注册研究(n=88 894)和UCC-SMART队列(n=5506)的CAD患者,采用潜在类别分析进行无监督机器学习聚类,在SWEDEHEART中聚类并在UCC-SMART中验证。
主要发现
- 聚类1(38%,n=33 777)主要为较年轻男性,体重指数、血压和C反应蛋白升高。
- 聚类2(21%,n=18 775)为吸烟者且传统危险因素较少;聚类3(30%,n=26 501)为较年长且合并症少的患者;聚类4(11%,n=9841)为多病共存患者。
- 以聚类1为参照,聚类4的复合终点风险最高(HR 4.38,95%CI 4.01–4.78),聚类3为HR 1.78(95%CI 1.70–1.85),聚类2为HR 0.97(95%CI 0.88–1.07)。
- 在UCC-SMART队列验证得到相似结果。
临床怎么用
- 该表型分型可能有助于临床识别复发心血管事件高风险CAD患者,但尚需研究特定病理生理机制和治疗效应差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guideline recommendations for the prevention of cardiovascular (CV) events in patients with coronary artery disease (CAD) are predominantly one-size-fits-all. Clinically identifiable phenotypes needing specific considerations might exist. The purpose of this study is to identify such clinical phenotypic clusters in patients with CAD and assess their relationship with the risk of recurrent CV events. METHODS: Unsupervised machine learning through latent class analysis was performed in patients with CAD from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) registry (n=88 894) and Utrecht Cardiovascular Cohort-Second Manifestations of Arterial Disease (UCC-SMART) cohort (n=5506). Characteristics for clustering were based on availability, missingness and clinical relevance. Clustering was performed in SWEDEHEART and validated in UCC-SMART. Association between clusters and the composite of myocardial infarction, stroke or CV death was assessed using Cox proportional hazard models. RESULTS: Four phenotypes could be distinguished: cluster 1 (38%, n=33 777) of predominantly younger males with increased body mass index, blood pressure and C-reactive protein, cluster 2 (21%, n=18 775) of smokers with few traditional risk factors, cluster 3 (30%, n=26 501) of older patients with few comorbidities and cluster 4 (11%, n=9841) of patients with multimorbidity. Compared with cluster 1, cluster 4 was at the highest risk (HR 4.38 95% CI (4.01 to 4.78)), followed by cluster 3 (HR 1.78 (1.70 to 1.85)), and cluster 2 (HR 0.97 (0.88 to 1.07)). Validation in UCC-SMART yielded similar results. CONCLUSION: Four distinct and reproducible phenotypes, with differences in the risk of recurrent CV events, were identified among patients with CAD. These may be relevant in practice and warrant research into specific pathophysiology and differences in treatment effects.
引用
- Holtrop J, Lim CE, Uijl A, et al. Identifying clinical phenotype clusters in patients with coronary artery disease. Heart. 2026. PMID: 40451277. doi:10.1136/heartjnl-2025-325740
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。